Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1

Cardiovasc Res. 2020 May 1;116(6):1125-1135. doi: 10.1093/cvr/cvz230.

Abstract

Aims: T-lymphocytes plays an important role in the pathophysiology of acute coronary syndromes. T-cell activation in vitro by pro-inflammatory cytokines may lead to functional tissue factor (TF) expression, indicating a possible contribution of immunity to thrombosis. Oxidized low-density lipoproteins (oxLDLs) are found abundantly in atherosclerotic plaques. We aimed at evaluating the effects of oxLDLs on TF expression in T cells and the role of the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).

Methods and results: CD3+ cells were isolated from healthy volunteers. Gene, protein, and surface expression of TF, as well as of LOX-1, were assessed at different time-points after oxLDL stimulation. To determine whether oxLDL-induced TF was LOX-1 dependent, T cells were pre-incubated with an LOX-1 inhibiting peptide (L-RBP) or with an anti-LOX-1 blocking antibody. To exclude that TF expression was mediated by reactive oxygen species (ROS) generation, oxLDL-stimulated T cells were pre-incubated with superoxide dismutase + catalase or with 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol), an intracellular free radical scavenger. Finally, to determine if the observed findings in vitro may have a biological relevance, the presence of CD3+/TF+/LOX-1+ cells was evaluated by immunofluorescence in human carotid atherosclerotic lesions. oxLDLs induced functionally active TF expression in T cells in a dose- and time-dependent manner, independently on ROS generation. No effect was observed in native LDL-treated T cells. LOX-1 expression was also induced by oxLDLs in a time- and dose-dependent manner. Pre-incubation with L-RBP or anti-LOX-1 antibody almost completely inhibited oxLDL-mediated TF expression. Interestingly, human carotid plaques showed significant infiltration of CD3+ cells (mainly CD8+ cells), some of which were positive for both TF and LOX-1.

Conclusion: oxLDLs induce functional TF expression in T-lymphocytes in vitro via interaction of oxLDLs with LOX-1. Human carotid atherosclerotic plaques contain CD3+/CD8+cells that express both TF and LOX-1, indicating that also in patients these mechanisms may play an important role.

Keywords: Atherosclerosis; Inflammation; Lipoproteins; T-lymphocyte; Tissue factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotid Artery Diseases / genetics
  • Carotid Artery Diseases / metabolism*
  • Carotid Artery Diseases / pathology
  • Cells, Cultured
  • Humans
  • Lipoproteins, LDL / pharmacology*
  • NADPH Oxidases / metabolism
  • NF-kappa B / metabolism
  • Plaque, Atherosclerotic
  • Reactive Oxygen Species / metabolism
  • Scavenger Receptors, Class E / agonists*
  • Scavenger Receptors, Class E / genetics
  • Scavenger Receptors, Class E / metabolism
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • Thromboplastin / genetics
  • Thromboplastin / metabolism*
  • Up-Regulation

Substances

  • Lipoproteins, LDL
  • NF-kappa B
  • OLR1 protein, human
  • Reactive Oxygen Species
  • Scavenger Receptors, Class E
  • oxidized low density lipoprotein
  • Thromboplastin
  • NADPH Oxidases